Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit J Arsenault

Showing results (71-80 of 159) with videos related to

Pageof 16
Sort By:
Aging Cell|October 27, 2021
A trans-omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseasesNicolas Perrot, William Pelletier, Jérôme Bourgault, et al.
Journal of the American College of Cardiology|April 2, 2011
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trialsDavid D Waters, Jennifer E Ho, David A DeMicco, et al.
Neurology|January 23, 2024
Mendelian Randomization Applied to Neurology: Promises and ChallengesEloi Gagnon, Iyas Daghlas, Loukas Zagkos, et al.
European Heart Journal Open|June 27, 2024
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targetsEloi Gagnon, Arnaud Girard, Jérôme Bourgault, et al.
Clinical Chemistry|March 30, 2010
Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle sizeBenoit J Arsenault, Isabelle Lemieux, Jean-Pierre Després, et al.
Journal of the American Heart Association|March 13, 2025
Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve StenosisArnaud S Girard, Audrey Paulin, Hasanga D Manikpurage, et al.
European Journal of Clinical Investigation|July 18, 2013
Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population studyBrigitte M Sondermeijer, Jamal S Rana, Benoit J Arsenault, et al.
Circulation|March 31, 2012
Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) studySamia Mora, Nanette K Wenger, David A Demicco, et al.
CJC Open|January 18, 2021
Correlates of Coronary Artery Calcification Prevalence and Severity in Patients With Heterozygous Familial HypercholesterolemiaJean-Philippe Drouin-Chartier, André J Tremblay, Dominic Godbout, et al.
The American Journal of Cardiology|March 4, 2014
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)Benoit J Arsenault, S Matthijs Boekholdt, Samia Mora, et al.
Pageof 16

Showing results (71-80 of 159) with videos related to

Sort By:
Pageof 16
Aging Cell|October 27, 2021
A trans-omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseasesNicolas Perrot, William Pelletier, Jérôme Bourgault, et al.
Journal of the American College of Cardiology|April 2, 2011
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trialsDavid D Waters, Jennifer E Ho, David A DeMicco, et al.
Neurology|January 23, 2024
Mendelian Randomization Applied to Neurology: Promises and ChallengesEloi Gagnon, Iyas Daghlas, Loukas Zagkos, et al.
European Heart Journal Open|June 27, 2024
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targetsEloi Gagnon, Arnaud Girard, Jérôme Bourgault, et al.
Clinical Chemistry|March 30, 2010
Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle sizeBenoit J Arsenault, Isabelle Lemieux, Jean-Pierre Després, et al.
Journal of the American Heart Association|March 13, 2025
Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve StenosisArnaud S Girard, Audrey Paulin, Hasanga D Manikpurage, et al.
European Journal of Clinical Investigation|July 18, 2013
Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population studyBrigitte M Sondermeijer, Jamal S Rana, Benoit J Arsenault, et al.
Circulation|March 31, 2012
Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) studySamia Mora, Nanette K Wenger, David A Demicco, et al.
CJC Open|January 18, 2021
Correlates of Coronary Artery Calcification Prevalence and Severity in Patients With Heterozygous Familial HypercholesterolemiaJean-Philippe Drouin-Chartier, André J Tremblay, Dominic Godbout, et al.
The American Journal of Cardiology|March 4, 2014
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)Benoit J Arsenault, S Matthijs Boekholdt, Samia Mora, et al.
Pageof 16